🔴 IDEXX is trading 5.75% down with no clear company-specific catalyst

IDEXX is trading 5.75% down at $548.94 on October 30, 2026, with no clear company-specific announcement identified to explain the decline.

• UBS cut its price target to $627 from $670 on October 27; that earlier action does not establish the reason for the current move.
• IDEXX’s third-quarter results are scheduled for November 2 and have not yet been reported.
• Healthcare-sector strength was reported, so it does not explain IDEXX’s decline.